Literature DB >> 17111077

The correlation between serum prostate specific antigen levels and asymptomatic inflammatory prostatitis.

Cuneyt Ozden1, Ozdem Levent Ozdal, Ozer Guzel, Ozge Han, Selda Seckin, Ali Memis.   

Abstract

INTRODUCTION: Asymptomatic inflammatory prostatitis is a common pathological finding in patients with benign prostatic hyperplasia (BPH). In the present study, we evaluated the correlation between serum prostate specific antigen (PSA) level and extent and aggressiveness of inflammation in surgical specimens of patients who underwent to surgery for BPH without any evidence of clinical prostatitis.
METHODS: Histological sections of the prostatic tissues of 52 patients were scored for the extent of inflammation and aggressiveness of inflammation, using the four point scale designed by Irani et al. Extent of inflammation is graded from 0 to 3 according to the degree of invasion of inflammatory cells in prostate tissue. Aggressiveness of inflammation is graded from 0 to 3 according to the degree of contact or disruption of prostatic glandular epithelium by inflammatory cells. The serum PSA levels in different inflammation grades were compared.
RESULTS: There was a significant correlation between inflammation and aggressiveness scores (r = 0.39, P < 0.01). Median PSA levels in grades 1, 2 and 3 extent of inflammation were 2.4, 5.2 and 5.7 ng/ml, respectively. There was not any significant difference between these grades for PSA. Furthermore, median PSA levels in grades 1, 2 and 3 aggressiveness of inflammation were 4.4, 4.8 and 8.7 ng/ml, respectively. There was a significant difference between grades of aggressiveness of inflammation and PSA levels.
CONCLUSION: High serum PSA levels may correlate with asymptomatic inflammatory prostatitis with high aggressiveness score in BPH patients without clinical prostatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111077     DOI: 10.1007/s11255-006-9125-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study.

Authors:  Lucila Heloisa Simardi; Marcos Tobias-MacHado; Guilherme Tommasi Kappaz; Patricia Taschner Goldenstein; Jeannette M Potts; Eric Roger Wroclawski
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

2.  Effects of chronic bacterial prostatitis on prostate specific antigen levels total and free in patients with benign prostatic hyperplasia and prostate cancer.

Authors:  Mohammed Nizar G Battikhi; Hussein Ismail; Qusey Battikhi
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men.

Authors:  J T Anim; E O Kehinde; A Prasad; M Sheikh; O A Mojiminiyi; Y Ali; K Al-Awadi
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens.

Authors:  B H Gümüş; N Neşe; M I Gündüz; A R Kandiloglu; Y Ceylan; C Büyüksu
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

5.  Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer.

Authors:  K Okada; M Kojima; Y Naya; K Kamoi; K Yokoyama; T Takamatsu; T Miki
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

6.  Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density.

Authors:  P H Schatteman; L Hoekx; J J Wyndaele; W Jeuris; E Van Marck
Journal:  Eur Urol       Date:  2000-04       Impact factor: 20.096

7.  Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation.

Authors:  Onder Yaman; Cağatay Göğüş; Ozden Tulunay; Zafer Tokatli; Eriz Ozden
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

8.  Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

Authors:  M C Benson; I S Whang; A Pantuck; K Ring; S A Kaplan; C A Olsson; W H Cooner
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.

Authors:  J Morote Robles; A Ruibal Morell; J Palou Redorta; J A de Torres Mateos; A Soler Roselló
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

10.  Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Authors:  William J Catalona; Jerome P Richie; Frederick R Ahmann; M'Liss A Hudson; Peter T Scardino; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

View more
  16 in total

1.  Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.

Authors:  B A Rybicki; O N Kryvenko; Y Wang; M Jankowski; S Trudeau; D A Chitale; N S Gupta; A Rundle; D Tang
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-12-01       Impact factor: 5.554

2.  Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer.

Authors:  M H Umbehr; B Gurel; T J Murtola; S Sutcliffe; S B Peskoe; C M Tangen; P J Goodman; I M Thompson; S M Lippman; M S Lucia; H L Parnes; C G Drake; W G Nelson; A M De Marzo; E A Platz
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-05-05       Impact factor: 5.554

3.  Nutraceuticals in Prostate Disease: The Urologist's Role.

Authors:  J Curtis Nickel; Daniel Shoskes; Claus G Roehrborn; Mark Moyad
Journal:  Rev Urol       Date:  2008

4.  Changes in serum prostate-specific antigen after treatment with antibiotics in patients with lower urinary tract symptoms/benign prostatic hyperplasia with prostatitis.

Authors:  Yoon-Soo Kyung; Hyeoung-Cheol Lee; Hyung-Jee Kim
Journal:  Int Neurourol J       Date:  2010-08-31       Impact factor: 2.835

5.  The role of empiric antibiotic treatment in preventing unnecessary prostate biopsies in asymptomatic patients with PSA levels between 4 and 10 ng/ml.

Authors:  Ali Saribacak; Hasan Yilmaz; Seyfettin Ciftci; Murat Ustuner; Levend Ozkan; Tayyar Alp Ozkan; Ozdal Dillioglugil
Journal:  Int J Clin Exp Med       Date:  2014-08-15

6.  The correlation of extent and grade of inflammation with serum PSA levels in patients with IV prostatitis.

Authors:  Li Gui-Zhong; Man Libo; Huang Guanglin; Wang Jianwei
Journal:  Int Urol Nephrol       Date:  2010-09-05       Impact factor: 2.370

7.  The role of National Institutes of Health category IV prostatitis in accurately staging the newly diagnosed prostate cancer.

Authors:  E Aglamis; C Tasdemir; C Ceylan
Journal:  Ir J Med Sci       Date:  2013-02-01       Impact factor: 1.568

8.  Antibacterial therapy improves the effectiveness of prostate cancer detection using prostate-specific antigen in patients with asymptomatic prostatitis.

Authors:  Ping Tang; Ke-Ji Xie; Bin Wang; Xiang-Rong Deng; Ru-Biao Ou
Journal:  Int Urol Nephrol       Date:  2009-06-23       Impact factor: 2.370

9.  Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?

Authors:  Nurullah Hamidi; Ali Fuat Atmaca; Abdullah Erdem Canda; Murat Keske; Arslan Ardıçoğlu
Journal:  Turk J Urol       Date:  2018-08-31

10.  Prostate Cancer Can Be Detected Even in Patients with Decreased PSA Less than 2.5 ng/ml after Treatment of Chronic Prostatitis.

Authors:  Young Jung Kim; Sun-Ouck Kim; Kwang Ho Ryu; In Sang Hwang; Eu Chang Hwang; Kyung Jin Oh; Seung Il Jung; Taek Won Kang; Dong Deuk Kwon; Kwangsung Park; Soo Bang Ryu
Journal:  Korean J Urol       Date:  2011-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.